Showing 1,461 - 1,480 results of 2,479 for search 'ITV2~', query time: 1.11s Refine Results
  1. 1461
  2. 1462
  3. 1463
  4. 1464
  5. 1465
  6. 1466
  7. 1467
  8. 1468
  9. 1469
  10. 1470
  11. 1471
  12. 1472
  13. 1473
  14. 1474
  15. 1475
  16. 1476
  17. 1477
  18. 1478
  19. 1479
  20. 1480

    Access to Diagnostics and Treatment for People With Metastatic EGFR-Positive NSCLC: Lessons From Project PRIORITY by Jill Feldman, MA, Ivy Elkins, MBA, Zofia Piotrowska, MD, Bellinda L. King-Kallimanis, PhD, Tendai Chihuri, MD, Carly Johnson, BS, Alecia Clary, PhD, Teri Kennedy, MA, Upal Basu Roy, PhD, MPH

    Published 2025-03-01
    “…In addition, 89% reported receiving at least one tyrosine kinase inhibitor (TKI); osimertinib was the most prescribed first-line TKI for stage IV participants diagnosed after 2017. Participants residing in the United States were more likely to have access to advanced diagnostic (next-generating sequencing) and newer treatments such as osimertinib. …”
    Get full text
    Article